Medical Advocates
New and Noteworthy
June 23, 2017

Featured Report
Clinical Management Update
Drug Update
Diagnostic/Monitoring Update
Marginalized Update
US Update
Global Update
Today's Video

Home Page

This web page is best viewed by using INTERNET EXPLORER
All Citations are abstracts UNLESS OTHERWISE NOTED
Today's Featured Report

The Evolving Interplay among Abundant Adipokines in Patients with Hepatitis C during Viral Clearance.
Chang ML, Hsu CM, Lin CH,et al
Nutrients. 2017 Jun 2;9(6). pii: E570.

Hepatics C Infection/Disease

Disease Management Update
  No one size fits all - shortening duration of therapy with direct acting antivirals for Hepatitis C genotype 1 infection.
El Sherif O, Afhdal N, Curry M.
J Viral Hepat. 2017 Jun 5.


Hepatics C Infection/Disease

Drug Update
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study.
Gane EJ, DeJesus E, Janczewska E,  et al 
BMC Infect Dis. 2017 Jun 2;17(1):


Diagnostic/Monitoring Update
  Evaluation of the COBAS AmpliPrep/COBAS<TaqMan<sup>®</sup> HCV Test v2.0 for HCV viral load monitoring using dried blood spot specimens.
Marins EG, Bodinaidu K, Lin M, Deforest A.
J Virol Methods. 2017 May 30



Marginalized Update
  Hospital admissions for HIV-infected prisoners in Italy.
Pontali E, Ranieri R, Rastrelli E,et al
 nt J Prison Health. 2017 Jun 12;13(2):


US Update
Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations.
Moreno GA, Wang A, Sánchez González Y, et al  
Value Health
. 2017 Jun;20(6):736-744.


Hepatics C Infection/Disease

Global Update

Today's Video

Mississippi's HIV Crisis


 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

The New and Noteworthy Web features a daily interdisciplinary focus on current journal, conference,
and video reports on clinical, political, ethical, spiritual, economic, and human rights
dimensions of life-threatening infectious diseases and violence, and the related challenges to
the marginalized affected by these diseases and behaviors.